» Articles » PMID: 26796235

The CD44 Ligand Hyaluronic Acid is Elevated in the Cerebrospinal Fluid of Suicide Attempters and is Associated with Increased Blood-brain Barrier Permeability

Overview
Journal J Affect Disord
Date 2016 Jan 23
PMID 26796235
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The glycosaminoglycan hyaluronic acid (HA) is an important component of the extracellular matrix (ECM) in the brain. CD44 is a cell adhesion molecule that binds to HA in the ECM and is present on astrocytes, microglia and certain neurons. Cell adhesion molecules have been reported to be involved in anxiety and mood disorders. CD44 levels are decreased in the cerebrospinal fluid (CSF) of depressed individuals, and the CD44 gene has been identified in brain GWAS studies as a possible risk gene for suicidal behavior.

Method: We measured the CSF levels of HA and the soluble CD44 (sCD44) in suicide attempters (n=94) and in healthy controls (n=45) using ELISA and electrochemiluminescence assays. We also investigated other proteins known to interact with CD44, such as osteopontin and the matrix metalloproteinases MMP1, MMP3 and MMP9.

Results: The suicide attempters had higher CSF levels of HA (p=.003) and MMP9 (p=.004). The CSF levels of HA correlated with BBB-permeability (rho=0.410, p<.001) and MMP9 correlated with sCD44 levels (rho=0.260, p=.005).

Limitations: Other relevant biological contributors to suicidal behavior is not addressed in parallel to the specific role of CD44-HA signaling. The gender distribution of the patients from whom CSF was analyzed was uneven.

Conclusions: Increased BBB-permeability and HA levels might be a results of increased neuroinflammation and can play a role in the pathobiology of suicidal behavior. The CD44 signaling pathway might be considered a novel target for intervention in mood disorders.

Citing Articles

Childhood trauma cortisol and immune cell glucocorticoid transcript levels are associated with increased risk for suicidality in adolescence.

Goltser-Dubner T, Benarroch F, Lavon M, Amer R, Canetti L, Giesser R Mol Psychiatry. 2025; .

PMID: 39994424 DOI: 10.1038/s41380-025-02923-3.


Reactive Astrocytosis-A Potential Contributor to Increased Suicide in Long COVID-19 Patients?.

Costanza A, Amerio A, Aguglia A, Rossi M, Parise A, Magnani L Brain Sci. 2024; 14(10).

PMID: 39451987 PMC: 11505806. DOI: 10.3390/brainsci14100973.


Glial Markers of Suicidal Behavior in the Human Brain-A Systematic Review of Postmortem Studies.

Yamamoto M, Sakai M, Yu Z, Nakanishi M, Yoshii H Int J Mol Sci. 2024; 25(11).

PMID: 38891940 PMC: 11171620. DOI: 10.3390/ijms25115750.


Peripheral blood BDNF and soluble CAM proteins as possible markers of prolonged disorders of consciousness: a pilot study.

Coppola L, Smaldone G, Grimaldi A, Estraneo A, Magliacano A, Soddu A Sci Rep. 2024; 14(1):341.

PMID: 38172270 PMC: 10764320. DOI: 10.1038/s41598-023-50581-8.


Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances.

Golub A, Ordak M, Nasierowski T, Bujalska-Zadrozny M Int J Mol Sci. 2023; 24(11).

PMID: 37298365 PMC: 10253383. DOI: 10.3390/ijms24119413.